Mustang Bio Operating Expenses Growth & History (MBIO)
Mustang Bio's operating expenses was $2.4M for fiscal 2025.
View full Mustang Bio company overviewMustang Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.4M | −$13.8M | −85.03% |
| 2024 | 2024-12-31 | $16.2M | −$33.0M | −67.02% |
| 2023 | 2023-12-31 | $49.3M | −$26.9M | −35.32% |
| 2022 | 2022-12-31 | $76.2M | $9.4M | +14.14% |
| 2021 | 2021-12-31 | $66.7M | $9.9M | +17.46% |
| 2020 | 2020-12-31 | $56.8M | $10.9M | +23.80% |
| 2019 | 2019-12-31 | $45.9M | $14.7M | +46.96% |
| 2018 | 2018-12-31 | $31.2M | −$562,000 | −1.77% |
| 2017 | 2017-12-31 | $31.8M | $20.4M | +179.72% |
| 2016 | 2016-12-31 | $11.4M | — | — |
Mustang Bio quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.2M | $285,000 | +32.20% |
| Q1 2026 | 2026-03-31 | $1.1M | $805,000 | +318.18% |
| Q4 2025 | 2025-12-31 | $670,000 | −$347,000 | −34.12% |
| Q3 2025 | 2025-09-30 | $624,000 | −$833,000 | −57.17% |
| Q2 2025 | 2025-06-30 | $885,000 | −$7.7M | −89.64% |
| Q1 2025 | 2025-03-31 | $253,000 | −$5.0M | −95.16% |
| Q4 2024 | 2024-12-31 | $1.0M | −$7.7M | −88.37% |
| Q3 2024 | 2024-09-30 | $1.5M | −$8.8M | −85.86% |
| Q2 2024 | 2024-06-30 | $8.5M | −$5.4M | −38.52% |
| Q1 2024 | 2024-03-31 | $5.2M | −$11.1M | −67.95% |
| Q4 2023 | 2023-12-31 | $8.7M | −$10.7M | −55.02% |
| Q3 2023 | 2023-09-30 | $10.3M | −$8.5M | −45.32% |
| Q2 2023 | 2023-06-30 | $13.9M | −$4.3M | −23.85% |
| Q1 2023 | 2023-03-31 | $16.3M | −$3.3M | −16.89% |
| Q4 2022 | 2022-12-31 | $19.4M | −$687,000 | −3.41% |
| Q3 2022 | 2022-09-30 | $18.8M | $1.8M | +10.37% |
| Q2 2022 | 2022-06-30 | $18.2M | $3.8M | +26.32% |
| Q1 2022 | 2022-03-31 | $19.6M | $4.6M | +30.17% |
| Q4 2021 | 2021-12-31 | $20.1M | −$619,000 | −2.98% |
| Q3 2021 | 2021-09-30 | $17.1M | $6.7M | +63.78% |
| Q2 2021 | 2021-06-30 | $14.4M | $319,000 | +2.26% |
| Q1 2021 | 2021-03-31 | $15.1M | $3.6M | +30.96% |
| Q4 2020 | 2020-12-31 | $20.7M | $4.8M | +30.24% |
| Q3 2020 | 2020-09-30 | $10.4M | $431,000 | +4.31% |
| Q2 2020 | 2020-06-30 | $14.1M | $3.9M | +38.28% |
| Q1 2020 | 2020-03-31 | $11.5M | $1.8M | +18.11% |
| Q4 2019 | 2019-12-31 | $15.9M | $4.0M | +33.81% |
| Q3 2019 | 2019-09-30 | $10.0M | $2.3M | +30.56% |
| Q2 2019 | 2019-06-30 | $10.2M | $5.0M | +94.89% |
| Q1 2019 | 2019-03-31 | $9.8M | $3.3M | +51.77% |
| Q4 2018 | 2018-12-31 | $11.9M | −$3.8M | −24.35% |
| Q3 2018 | 2018-09-30 | $7.7M | $572,000 | +8.07% |
| Q2 2018 | 2018-06-30 | $5.2M | −$425,000 | −7.50% |
| Q1 2018 | 2018-03-31 | $6.4M | $3.1M | +94.40% |
| Q4 2017 | 2017-12-31 | $15.7M | — | — |
| Q3 2017 | 2017-09-30 | $7.1M | $5.4M | +324.19% |
| Q2 2017 | 2017-06-30 | $5.7M | $4.6M | +444.71% |
| Q1 2017 | 2017-03-31 | $3.3M | — | — |
| Q3 2016 | 2016-09-30 | $1.7M | $1.0M | +153.80% |
| Q2 2016 | 2016-06-30 | $1.0M | — | — |
| Q3 2015 | 2015-09-30 | $658,000 | — | — |
Mustang Bio operating expenses trends
Over the last five fiscal years, Mustang Bio's operating expenses decreased from $56.8M to $2.4M, a change of −$54.4M. The latest reported quarter, Q2 2026, shows $1.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mustang Bio source filings ↗